RxDoctor Payments Data

Jennifer de la Rosa, DO

Family Medicine · West Burlington, IANPI 1417915208

Payments from drug & device makers

$518in general payments, 2019–2025

Across 29 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$97
  • Amgen$80
  • Novo Nordisk$79
  • AstraZeneca$51
  • Novartis$40
  • Roche Diagnostics Corporation$39
  • plus $133 from 7 others

What the payments were for

  • Food & beverage$518100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$518 in reported general payments places this provider in the 70th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$100,861
Medicare patients
327
Services billed
1,154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban97$100,055
JardianceEmpagliflozin31$42,544
OzempicSemaglutide27$24,644
XareltoRivaroxaban21$19,578
Lantus SolostarInsulin Glargine,hum.Rec.Anlog102$16,703
Stiolto RespimatTiotropium Br/Olodaterol Hcl16$16,441
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog30$12,270
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,749
Arnuity ElliptaFluticasone Furoate24$9,470
Tresiba Flextouch U-200Insulin Degludec17$7,615
FarxigaDapagliflozin Propanediol11$6,426
Levothyroxine Sodium482$3,359
Gabapentin208$2,811
Atorvastatin Calcium446$2,713
Metoprolol Succinate199$2,627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$26$100,05597 claims
Boehringer IngelheimJardiance, Stiolto Respimat$11$58,98547 claims
Novo NordiskOzempic$79$24,64427 claims
AstraZenecaFarxiga$51$6,42611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in West Burlington

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →